Endophytic Consortium With Diverse Gene-Regulating Capabilities of Benzylisoquinoline Alkaloids Biosynthetic Pathway Can Enhance Endogenous Morphine Biosynthesis in Papaver somniferum

Tania Ray,Shiv S. Pandey,Alok Pandey,Madhumita Srivastava,Karuna Shanker,Alok Kalra
DOI: https://doi.org/10.3389/fmicb.2019.00925
IF: 5.2
2019-04-30
Frontiers in Microbiology
Abstract:Secondary metabolite biosynthesis in medicinal plants is multi-step cascade known to be modulated by associated endophytes. While a single endophyte is not able to upregulate all biosynthetic steps, limiting maximum yield achievement. Therefore to compliment the deficient characteristics in an endophyte we tried consortium of endophytes to achieve maximum yield. Here, efforts were made to maximize the <i>in planta</i> morphine yield, using consortium of two endophytes; SM1B (<i>Acinetobacter</i> sp.) upregulating most of the genes of morphine biosynthesis except <i>T6ODM</i> and <i>CODM</i>, and SM3B (<i>Marmoricola</i> sp.) upregulating <i>T6ODM</i> and <i>CODM</i> in alkaloid-less <i>Papaver somniferum</i> cv. Sujata. Consortium-inoculation significantly increased morphine and thebaine content, and also increased the photosynthetic efficiency of poppy plants resulted in increased biomass, capsule weight, and seed yields compared to single-inoculation. The increment in morphine content was due to the modulation of metabolic-flow of key intermediates including reticuline and thebaine, via upregulating pertinent biosynthetic genes and enhanced expression of <i>COR</i>, key gene for morphine biosynthesis. This is the first report demonstrating the endophytic-consortium complimenting the functional deficiency of one endophyte by another for upregulating multiple genes of a metabolic pathway similar to transgenics (overexpressing multiple genes) for obtaining enhanced yield of pharmaceutically important metabolites.
microbiology
What problem does this paper attempt to address?